These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31967328)

  • 21. Drug fever due to a single dose of pantoprazole.
    Schiller D; Maieron A; Schöfl R; Donnerer J
    Pharmacology; 2014; 94(1-2):78-9. PubMed ID: 25228460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ashy dermatosis (erythema dyschromicum perstans) induced by omeprazole: a report of three cases.
    Chua S; Chan MM; Lee HY
    Int J Dermatol; 2015 Oct; 54(10):e435-6. PubMed ID: 26146873
    [No Abstract]   [Full Text] [Related]  

  • 23. Esomeprazole use is independently associated with significant reduction of BMD: 1-year prospective comparative safety study of four proton pump inhibitors.
    Bahtiri E; Islami H; Hoxha R; Qorraj-Bytyqi H; Rexhepi S; Hoti K; Thaçi K; Thaçi S; Karakulak Ç
    J Bone Miner Metab; 2016 Sep; 34(5):571-9. PubMed ID: 26209167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Esomeprazol-induced cutaneous lupus erythematosus].
    Gliem N; Broekaert SMC; Seitz CS; Schön MP; Ellenrieder V
    Z Gastroenterol; 2017 Sep; 55(9):861-865. PubMed ID: 29186640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agranulocytosis induced by proton pump inhibitors.
    Dury S; Nardi J; Gozalo C; Lebargy F; Deslee G
    J Clin Gastroenterol; 2012; 46(10):859. PubMed ID: 22240865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute generalized exanthematous pustulosis induced by omeprazole].
    Nantes Castillejo O; Zozaya Urmeneta JM; Valcayo Peñalba A; Martínez-Peñuela Virseda JM
    Gastroenterol Hepatol; 2008 May; 31(5):295-8. PubMed ID: 18448060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypomagnesaemia/hypokalemia associated with the use of esomeprazole.
    Negri AL; Valle EE
    Curr Drug Saf; 2011 Jul; 6(3):204-6. PubMed ID: 22122397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis.
    Lovell DJ; Dare JA; Francis-Sedlak M; Ball J; LaMoreaux BD; Von Scheven E; Reinhardt A; Jerath R; Alpan O; Gupta R; Goldsmith D; Zeft A; Naddaf H; Gottlieb B; Jung L; Holt RJ
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):41. PubMed ID: 29941047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ménétrier Mimicker Complicating Ulcerative Colitis: Proton-Pump Inhibitor-Induced Hyperplastic Polyps.
    Parks T; Ragland KL; Steiner MA; Subramony C; Bishop P; Nowicki M
    J Pediatr; 2015 Sep; 167(3):776.e1. PubMed ID: 26209527
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxic megacolon after abdominoplasty: a case report.
    Wade JW
    Ann Plast Surg; 2014; 72(6):S170-1. PubMed ID: 24667886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
    Choi Y; Han H; Shin D; Lim KS; Yu KS
    Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
    Vakil NB; Shaker R; Johnson DA; Kovacs T; Baerg RD; Hwang C; D'Amico D; Hamelin B
    Aliment Pharmacol Ther; 2001 Jul; 15(7):927-35. PubMed ID: 11421866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug interaction: Clopidogrel and PPIs.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):39-40. PubMed ID: 28222065
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced subacute cutaneous lupus erythematosus associated with omeprazole.
    Toms-Whittle LM; John LH; Buckley DA
    Clin Exp Dermatol; 2011 Apr; 36(3):281-3. PubMed ID: 20738320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of esomeprazole, a proton pump inhibitor on the pharmacokinetics of sonidegib in healthy volunteers.
    Zhou J; Quinlan M; Glenn K; Boss H; Picard F; Castro H; Sellami D
    Br J Clin Pharmacol; 2016 Oct; 82(4):1022-9. PubMed ID: 27277189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Succession of duodenal polypoid lesion.
    Lin HJ; Chang CW; Chen MJ
    Gastroenterology; 2015 May; 148(5):e1-2. PubMed ID: 25824346
    [No Abstract]   [Full Text] [Related]  

  • 38. Association Between Proton Pump Inhibitors and Microscopic Colitis.
    Law EH; Badowski M; Hung YT; Weems K; Sanchez A; Lee TA
    Ann Pharmacother; 2017 Mar; 51(3):253-263. PubMed ID: 27733667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proton pump inhibitors (PPI) and photodistributed drug-induced eruption].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2007 Feb; 134(2):212. PubMed ID: 17375029
    [No Abstract]   [Full Text] [Related]  

  • 40. Lichenoid drug eruption with proton pump inhibitors.
    Bong JL; Lucke TW; Douglas WS
    BMJ; 2000 Jan; 320(7230):283. PubMed ID: 10650025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.